Takeda Pharmaceutical Co Ltd

4502: XTKS (JPN)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
LOCK|lh%LOCK|HhLOCK|yfnZ!f

Takeda Earnings: Slow Start to the Year, and Full-Year Guidance Unchanged

Takeda reported first-quarter revenue of JPY 1.11 trillion, or a 3.7% decline at constant currency and 8.4% decline on a reported basis. Management reiterated its full-year guidance and continues to expect broadly unchanged financial metrics compared with fiscal 2024.

Sponsor Center